A shared commitment to pursue new investigational therapies
If you are seeing patients that experience atopic dermatitis-related itch symptoms who may qualify to participate in a clinical trial for an investigational treatment, this study could be an option!
28 Days
Screening
If patients are still interested in the Soothe study after completing a patient application and pre-screening, they can review and sign a consent form to make an educated decision about participation and the study doctor will perform final assessments to confirm their eligibility to participate.
28 Days
Treatment
The study medication is being evaluated to determine the safety, effectiveness, tolerability, and PK in eczema-related itch. Patients will receive an investigational topical gel, or placebo, to apply twice daily and will be monitored for safety and study progress. Certain study visits will be discussed prior to participation and include: physical exams, electrocardiograms (ECGs), blood and urine samples, skin assessments and other tests and assessments conducted at the study site.
28 Days
Follow Up
After concluding the treatment period, the study doctor will conduct a follow up visit and debrief patients 28-days after the last topical application to thoroughly monitor and evaluate safety, effectiveness, tolerability, and PK.
How to connect your patients to the study
Speak with Patients
Speak with patients about the study and provide them with the patient information document by selecting the "Download Overview" button.
Share Questionnaire Link
Instruct patients to visit eczematrial.org/start or to call +1 646-440-1454 to complete a patient application form.
TrialSpark Prescreens Patients
A Nurse Enrollment Specialist will connect with patients to further assess potential eligibility and qualified patients will be referred to a study doctor.
Download More Information
If patients are interested in participating you can provide them with more information.
As a board-certified Dermatologist with a busy medical practice and research clinic, working with a knowledgeable, organized company on our clinical trials is key. It was truly a pleasure to collaborate with TrialSpark. They are proficient, organized, and responsive. It is evident that they really care about clinical research.
Brenda LaTowsky, MD
Investigate MD
As a board-certified Dermatologist with a busy medical practice and research clinic, working with a knowledgeable, organized company on our clinical trials is key. It was truly a pleasure to collaborate with TrialSpark. They are proficient, organized, and responsive. It is evident that they really care about clinical research.
Brenda LaTowsky, MD
Investigate MD
Check Us Out
Learn more about our commitment to helping connect your patients with a novel new approach to clinical trial research.